| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |